1 in 10 adults has diabetes.​
1 in 3 of them is at risk of vision loss from diabetic retinopathy.​
1 in 200 people lives with glaucoma.​
1 in 10 people over 50 is affected by AMD.​

Yet these vision-threatening diseases often go undetected because screening relies on specialist-heavy, slow, and hard-to-scale workflows, leaving millions unscreened.​

MediosHI 3 in1 AI addresses this by enabling fast, clinically reliable multi-disease screening from a single retinal image. Integrated into the Insta FOP NM 10, delivering on the edge results without  on-site specialists, supporting early detection and timely referral across clinics, eye hospitals, and large-scale screening programs.​ ​